Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 109 pembrolizumab 93 Pemetrexed 83 Cisplatin 67 Specimen Handling 41 durvalumab 36 Paclitaxel 36 Nivolumab 33 Docetaxel 33 atezolizumab 30 Magnetic Resonance Spectroscopy 30 osimertinib 29 Radiotherapy 21 Gemcitabine 21 Etoposide 21 130-nm albumin-bound paclitaxel 19 Cetuximab 17 amivantamab 14 Radiosurgery 13 Radiation 12 Platinum 12 Bevacizumab 12 lazertinib 11 cemiplimab 11 Taxes 11 Immunoglobulin G 11 Topotecan 10 Ipilimumab 10 Drug Therapy 10 Disulfides 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

aumolertinib × Thoracic × 30 days × Clear all

NCT04841811 2026-05-22

APPROACH

Guangdong Association of Clinical Trials

Phase 3 Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡